STING1 and asthma: To assess whether the model of asthma exacerbation induced by the STING agonist diABZI is glucocorticoid‐resistant, diABZI+HDM‐treated mice were treated with Budesonide (0.3 or 1 mg/kg i.n.)during the challenge phase (Figure 3A).